
    
      It has previously been established that hematological cancer patients with myelodysplastic
      syndrome (MDS) or acute myeloid leukemia (AML) often exhibit severe vitamin C deficiency from
      a cohort of patients in Copenhagen. In this study, the investigators aim to determine if
      those results are conserved in another population/geographical location.
    
  